Clinical Trials
10 trialsNCT05359146 2024-04-19
Beta plus
University Hospital, Basel, Switzerland
Phase EARLY_PHASE1 Unknown
NCT06217848 2024-01-23
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Seoul National University Hospital
Phase EARLY_PHASE1 Unknown
NCT04897542 2023-09-18
Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
NCT05034783 2022-10-14
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT02817945 2022-04-07
Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT02823691 2021-06-07
MetNET-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase EARLY_PHASE1 Unknown
NCT04185350 2019-12-04
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Nanjing First Hospital, Nanjing Medical University
Phase EARLY_PHASE1 Unknown
NCT04041882 2019-08-01
68Ga-DOTATATE PET/CT in Neuroendocrine Tumor
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT02560376 2015-09-25
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Unknown
NCT01417442 2011-08-16
BRAF V600E Mutations In Papillary Thyroid Carcinoma
Bezmialem Vakif University
Phase EARLY_PHASE1 Unknown